↑Wang W, McKinnie SM, Farhan M, Paul M, McDonald T, McLean B, Llorens-Cortes C, Hazra S, Murray AG, Vederas JC, Oudit GY (May 2016). "Angiotensin Converting Enzyme 2 Metabolizes and Partially Inactivates Pyrapelin-13 and Apelin-17: Physiological Effects in the Cardiovascular System". Hypertension. 68: 365–77. doi:10.1161/HYPERTENSIONAHA.115.06892. PMID27217402.
↑Boehm M, Nabel EG (Nov 2002). "Angiotensin-converting enzyme 2--a new cardiac regulator". The New England Journal of Medicine. 347 (22): 1795–7. doi:10.1056/NEJMcibr022472. PMID12456857.
↑Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, Huan Y, Yang P, Zhang Y, Deng W, Bao L, Zhang B, Liu G, Wang Z, Chappell M, Liu Y, Zheng D, Leibbrandt A, Wada T, Slutsky AS, Liu D, Qin C, Jiang C, Penninger JM (Aug 2005). "A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury". Nature Medicine. 11 (8): 875–9. doi:10.1038/nm1267. PMID16007097.
Turner AJ, Tipnis SR, Guy JL, Rice G, Hooper NM (Apr 2002). "ACEH/ACE2 is a novel mammalian metallocarboxypeptidase and a homologue of angiotensin-converting enzyme insensitive to ACE inhibitors". Canadian Journal of Physiology and Pharmacology. 80 (4): 346–53. doi:10.1139/y02-021. PMID12025971.
Turner AJ, Hiscox JA, Hooper NM (Jun 2004). "ACE2: from vasopeptidase to SARS virus receptor". Trends in Pharmacological Sciences. 25 (6): 291–4. doi:10.1016/j.tips.2004.04.001. PMID15165741.
Katovich MJ, Grobe JL, Huentelman M, Raizada MK (May 2005). "Angiotensin-converting enzyme 2 as a novel target for gene therapy for hypertension". Experimental Physiology. 90 (3): 299–305. doi:10.1113/expphysiol.2004.028522. PMID15640278.
Ferrario CM, Trask AJ, Jessup JA (Dec 2005). "Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function". American Journal of Physiology. Heart and Circulatory Physiology. 289 (6): H2281–90. doi:10.1152/ajpheart.00618.2005. PMID16055515.
Jia HP, Look DC, Hickey M, Shi L, Pewe L, Netland J, Farzan M, Wohlford-Lenane C, Perlman S, McCray PB (2006). "Infection of human airway epithelia by SARS coronavirus is associated with ACE2 expression and localization". Advances in Experimental Medicine and Biology. 581: 479–84. doi:10.1007/978-0-387-33012-9_85. ISBN978-0-387-26202-4. PMID17037581.
Lazartigues E, Feng Y, Lavoie JL (2007). "The two fACEs of the tissue renin–angiotensin systems: implication in cardiovascular diseases". Current Pharmaceutical Design. 13 (12): 1231–45. doi:10.2174/138161207780618911. PMID17504232.
Raizada MK, Ferreira AJ (Aug 2007). "ACE2: a new target for cardiovascular disease therapeutics". Journal of Cardiovascular Pharmacology. 50 (2): 112–9. doi:10.1097/FJC.0b013e3180986219. PMID17703127.
Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ (Oct 2000). "A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase". The Journal of Biological Chemistry. 275 (43): 33238–43. doi:10.1074/jbc.M002615200. PMID10924499.
Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan R, Breitbart RE, Acton S (Sep 2000). "A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9". Circulation Research. 87 (5): E1–9. doi:10.1161/01.res.87.5.e1. PMID10969042.
Vickers C, Hales P, Kaushik V, Dick L, Gavin J, Tang J, Godbout K, Parsons T, Baronas E, Hsieh F, Acton S, Patane M, Nichols A, Tummino P (Apr 2002). "Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase". The Journal of Biological Chemistry. 277 (17): 14838–43. doi:10.1074/jbc.M200581200. PMID11815627.
Crackower MA, Sarao R, Oudit GY, Yagil C, Kozieradzki I, Scanga SE, Oliveira-dos-Santos AJ, da Costa J, Zhang L, Pei Y, Scholey J, Ferrario CM, Manoukian AS, Chappell MC, Backx PH, Yagil Y, Penninger JM (Jun 2002). "Angiotensin-converting enzyme 2 is an essential regulator of heart function". Nature. 417 (6891): 822–8. doi:10.1038/nature00786. PMID12075344.
Harmer D, Gilbert M, Borman R, Clark KL (Dec 2002). "Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme". FEBS Letters. 532 (1–2): 107–10. doi:10.1016/S0014-5793(02)03640-2. PMID12459472.
Donoghue M, Wakimoto H, Maguire CT, Acton S, Hales P, Stagliano N, Fairchild-Huntress V, Xu J, Lorenz JN, Kadambi V, Berul CI, Breitbart RE (Sep 2003). "Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins". Journal of Molecular and Cellular Cardiology. 35 (9): 1043–53. doi:10.1016/S0022-2828(03)00177-9. PMID12967627.
Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC, Choe H, Farzan M (Nov 2003). "Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus". Nature. 426 (6965): 450–4. doi:10.1038/nature02145. PMID14647384.
Wong SK, Li W, Moore MJ, Choe H, Farzan M (Jan 2004). "A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2". The Journal of Biological Chemistry. 279 (5): 3197–201. doi:10.1074/jbc.C300520200. PMID14670965.
Towler P, Staker B, Prasad SG, Menon S, Tang J, Parsons T, Ryan D, Fisher M, Williams D, Dales NA, Patane MA, Pantoliano MW (Apr 2004). "ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis". The Journal of Biological Chemistry. 279 (17): 17996–8007. doi:10.1074/jbc.M311191200. PMID14754895.